Thinking of joining a study?

Register your interest

NCT04430426 | NOT YET RECRUITING | Kidney Stone


Heterozygous Individuals for AGXT and Kidney Stones
Sponsor:

University of Alabama at Birmingham

Information provided by (Responsible Party):

Kyle D. Wood

Brief Summary:

This study seeks to examine the effects of a heterozygous mutation of the AGXT gene in a stone forming population on endogenous oxalate production. Participants will consume a controlled low-oxalate diet and provide blood and urine samples to measure the amount of oxalate in their bodies. Subjects will then be administered an intravenous (IV) load of glycolate, providing additional blood and urine samples afterwards to measure any increase in oxalate levels.

Condition or disease

Kidney Stone

Intervention/treatment

Controlled Diet

Glycolate Administration

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 4 participants
Masking : NONE
Primary Purpose : OTHER
Official Title : Heterozygous Individuals for AGXT and Kidney Stones
Actual Study Start Date : 2025-07-01
Estimated Primary Completion Date : 2026-08
Estimated Study Completion Date : 2026-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * at least 18 years of age
  • * history of calcium oxalate stones
  • * heterozygous mutation of the AGXT gene, as evidenced by results from the Invitae Nephrolithiasis Panel
  • * willingness to comply with a controlled diet for five days
Exclusion Criteria
  • * pregnant individuals
  • * individuals who are currently breast feeding

Heterozygous Individuals for AGXT and Kidney Stones

Location Details

NCT04430426


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...